NEW YORK (GenomeWeb) – Sophia Genetics, a developer of bioinformatics for analyzing genetic test data, today said that it has raised $13.75 million in a Series B financing round.

The Lausanne, Switzerland-based company offers a software as a service called dropGen, which provides bioinformatic analyis, the validation and quality control process, and the presentation of genetic test results to clinicians while protecting patient DNA sequence data through safe storage and banking, it said.

The financing round was led by Invoke Capital, Swisscom, and Endeavour Vision.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.